webchem
Adding chemical databases with one hand while public ones close programmatic access with the other.
Comparison · Analytics
logrx vs serofoi
A side-by-side editorial comparison of logrx and serofoi — release velocity, themes, recent moves, and the top alternatives to consider.
logrx vs serofoi: at a glance
What is logrx?
A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.
logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.
What is serofoi?
serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.
serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.
logrx vs serofoi: editorial side-by-side
logrx
0.0ANALYTICS
A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.
◆ Current state
logrx produces execution logs for R scripts in regulated clinical work, recording what ran, what it returned, and which unapproved packages or functions were used. Its release notes are raw merged-PR lists rather than written changelogs, which makes the substance hard to read from the feed. The most recent release, 0.2.2 in June 2023, exists to track tidyselect and dplyr changes.
◆ Where it's heading
Feature work concentrated in the 0.1 line — return codes, a results writer, a to_report parameter, and logging of unapproved package and function use — and the 0.2 releases have been compatibility maintenance and hotfixes. Three years of silence in a pharmaverse that has otherwise kept shipping suggests the package reached the shape its users needed rather than that it was abandoned mid-design.
◆ Prediction
Nothing in these entries points to planned work; the likeliest trigger for a release is a breaking change in tidyverse dependencies, which is what produced the last one.
serofoi
0.0ANALYTICS
serofoi grew a serosurvey simulator alongside the force-of-infection models it was built to fit.
◆ Current state
serofoi estimates the force of infection from serological survey data using Bayesian serocatalytic models fitted through Stan. Beyond fitting it now simulates serosurveys — specifying a model and a survey design and generating the data such a survey would produce. The most recent release is visualisation and naming work.
◆ Where it's heading
The package moved from fitting-only to a fit-and-simulate pair. 0.1.0 added simulation from time- or age-varying force-of-infection trends and simplified the fitted object down to a Stan fit; 1.0.2 broadened simulation into full serosurvey generation with its own vignette. 1.0.3 then spent its effort on naming consistency and plotting options, which is what a package does once its scope is set.
◆ Prediction
With simulation and fitting both in place, the natural next step is tooling that closes the loop between them — recovery checks or study-design guidance built on simulated surveys.
Alternatives to logrx and serofoi
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either logrx or serofoi.
sftime
The spatiotemporal companion to sf, moving at the pace of the packages around it.
ReLTER
An interface to Europe's long-term ecosystem research network that went quiet after 2.0.
waywiser
Spatial model assessment that spent the last year on cross-platform arithmetic and CRAN rules.
taxizedb
Stopped trusting the cloud to prepare its taxonomic databases and does the conversion locally.
fellingdater
Went from estimating felling dates to doing the crossdating that produces them.
See all logrx alternatives → · See all serofoi alternatives →
Recent activity from logrx and serofoi
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 1y agoserofoiConstant FoI plots, r-hat plotting and shorter parameter names
- 1y agoserofoiSerological surveys can now be simulated end to end
- 2y agoserofoiSimulation functions added; fitted output simplified to a Stan fit
- 3y agoserofoiFirst release: three force-of-infection models and the core modules
- 3y agologrxAlignment with tidyselect and dplyr changes
- 3y agologrxRelease v0.2.1
- 3y agologrxFormatted log output plus CRAN readiness work
- 4y agologrxPackage renamed to logrx; return codes and results writer land
Frequently asked questions
What is the difference between logrx and serofoi?
They serve adjacent needs but don't currently overlap on shipped themes. logrx and serofoi are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is logrx better than serofoi?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. logrx and serofoi are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to logrx?
Top logrx alternatives in Analytics are ranked by recent ship velocity. Browse the "logrx alternatives" section above for the current picks, or visit /alternatives/logrx for the full list with editorial commentary on each.
What are the best alternatives to serofoi?
Top serofoi alternatives in Analytics are ranked by recent ship velocity. Browse the "serofoi alternatives" section above for the current picks, or visit /alternatives/serofoi for the full list with editorial commentary on each.